Home News Covid-19

Moderna says it has US$18.5 billion in vaccine orders for 2022

Bloomberg
Bloomberg1/10/2022 9:41 PM GMT+08  • 1 min read
Moderna says it has US$18.5 billion in vaccine orders for 2022
Analysts were expecting US$19.3 billion in Moderna Covid vaccine sales for 2022
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Moderna Inc. said it has signed vaccine purchase agreements worth US$18.5 billion ($25.1 billion) for this year, along with options for another US$3.5 billion, including booster shots.

In a statement on Monday, the company also said 2021 product sales would be US$17.5 billion, slightly higher than the average analyst estimate of US$17 billion, according to data compiled by Bloomberg. Additionally, the company said that it shipped 807 million vaccine doses in 2021. Previously, it had said it would deliver between 700 million and 800 million doses.

The advance purchase agreements for 2022 are up from US$17 billion worth of commitments it had announced last year. Analysts were expecting US$19.3 billion in Moderna Covid vaccine sales for 2022, according to a Bloomberg survey of analyst estimates.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.